Sofie Verhaeghe

Ghent University Hospital

Papers

1

Total Citations

28

H-Index

1

About

Sofie Verhaeghe is a leading researcher in health-related quality of life (HRQoL) outcomes for cancer patients, with a particular focus on urological oncology. Her work centers on synthesizing evidence to guide clinical decision-making, especially for muscle-invasive bladder cancer—a disease where treatment trade-offs between survival and quality of life are profound. In her landmark umbrella review (2020), which has garnered 28 citations, Verhaeghe systematically compared HRQoL outcomes across curative treatment options, including radical cystectomy and trimodal therapy. This work provides a critical framework for clinicians and patients navigating complex treatment choices, highlighting how different approaches impact physical, emotional, and social well-being. Beyond this, Verhaeghe’s research contributes to patient-centered care by integrating patient-reported outcomes into evidence-based practice. Her ability to distill vast, often conflicting literature into actionable insights has made her a key voice in oncology quality-of-life research. For students and researchers, Verhaeghe’s work exemplifies how rigorous synthesis can bridge the gap between clinical efficacy and patient experience, offering a model for translating complex data into meaningful clinical guidance.

Research Focus

Key Achievements

1
H-Index
1
Papers
28
Total Citations
28
Avg Citations/Paper
🏆 Most Cited Paper
Health-related quality of life overview after different curative treatment options in muscle-invasive bladder cancer: an umbrella review
28 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Ghent University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago